ESC 365 - Introduction - PCSK9i: translating LDL-C lowering into plaque regression and CV event reduction?

Open Access

Introduction - PCSK9i: translating LDL-C lowering into plaque regression and CV event reduction?

Session: PCSK9i: translating LDL-C lowering into plaque regression and CV event reduction?

Topic: Atherosclerosis

Speaker: Professor J. Kastelein (Amsterdam, NL)

Sponsored by Amgen Cardiovascular

Event: ESC Congress 2016

Congress Presentation

Add to my library

About the speaker

Professor John Kastelein

Faculty of Medecine - University of Amsterdam, Amsterdam (Netherlands (The))

34 presentations

6 followers

3 more presentations in this session

PCSK9i: impacting on plaque regression?

Speaker: Professor W. Koenig (Munich, DE)

PCSK9i: new horizons in CVD prevention?

Speaker: Professor K. Ray (London, GB)

Conclusion - PCSK9i: translating LDL-C lowering into plaque regression and CV event reduction?

Speaker: Professor J. Kastelein (Amsterdam, NL)

Access the full session

PCSK9i: translating LDL-C lowering into plaque regression and CV event reduction?

Speakers: Professor J. Kastelein, Professor W. Koenig, Professor K. Ray, Professor J. Kastelein

About the event

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources